Relation between oxidative stress, catecholamines, and impaired chronotropic response to exercise in patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

American Journal of Cardiology

Volumn 92, Issue 2, 2003, Pages 215-218

  Castro, Pablo F ^a   Greig, Douglas ^b   Pérez, Osvaldo ^b   Moraga, Francisco ^b   Chiong, Mario ^b   Díaz Araya, Guillermo ^b   Padilla, Ivonne ^b   Nazzal, Carolina ^b   Jalil, Jorge E ^b   Vukasovic, José Luis ^b   Moreno, Mauricio ^b   Corbalán, Ramón ^b   Lavandero, Sergio ^b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; CATECHOLAMINE; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; HYDRALAZINE PLUS ISOSORBIDE DINITRATE; LOSARTAN; MALONALDEHYDE; NORADRENALIN; REACTIVE OXYGEN METABOLITE; SPIRONOLACTONE;

ADRENALIN BLOOD LEVEL; ADULT; ANGINA PECTORIS; ANGIOPLASTY; ARTICLE; AUTOIMMUNE DISEASE; CARDIOMYOPATHY; CATECHOLAMINE BLOOD LEVEL; CELL DAMAGE; CHRONOTROPISM; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; DESENSITIZATION; DOPPLER ECHOCARDIOGRAPHY; EXERCISE; EXERCISE TEST; FEMALE; GAS EXCHANGE; HEART DILATATION; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE; HEART MUSCLE CELL; HEART RATE; HUMAN; HYPERTENSION; INFLAMMATION; INFORMED CONSENT; ISCHEMIC HEART DISEASE; LIPID PEROXIDATION; MALE; MEDICAL ETHICS; NORADRENALIN BLOOD LEVEL; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RADIOISOTOPE VENTRICULOGRAPHY; SIGNAL TRANSDUCTION; SYSTOLIC BLOOD PRESSURE; TREADMILL EXERCISE;

EID: 0037630728     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00543-5     Document Type: Article

References (19)

1. Ide T., Tsutsui H., Kinugawa S., Utsumi H., Kang D., Hattori N., Uchida K., Arimura K., Egashira K., Takeshita A. Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ Res. 85:1999;357-363.
2. Siwik D.A., Tzortzis J.D., Pimental D.R., Chang D.L., Pagano P.J., Singh K., Sawyer D.B., Colucci W.S. Inhibition of copper-zinc superoxide dismutase induces cell growth, hypertrophic phenotype and apoptosis in neonatal rat cardiac myocytes in vitro. Circ Res. 85:1999;147-153.
3. Nakamura K., Fushimi K., Kouchi H., Mihara K., Miyazaki M., Ohe T., Namba M. Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-α and angiotensin II. Circulation. 98:1998;794-799.
4. Nakamura K., Kusano K., Nakamura Y., Kakishita M., Ohta K., Nagase S., Yamamoto M., Miyaji K., Saito H., Morita H., et al. Carvedilol decreases elevated oxidative stress in human failing myocardium. Circulation. 105:2002;2867-2871.
5. Francis G.S., Goldsmith S.R., Levine T.B., Olivari M.T., Cohn J.N. The neurohumoral axis in congestive heart failure. Ann Intern Med. 101:1984;370-377.
6. Francis G.S., Benedict C., Johnstone D.E., Kirklin P.C., Nicklas J., Liang C.S., Kubo S.H., Rudin-Toretsky E., Yusuf S. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the studies of left ventricular dysfunction (SOLVD). Circulation. 82:1990;1724-1729.
7. Colucci W.S., Ribeiro J.P., Rocco M.B., Quigg R.J., Creager M.A., Marsh J.D., Gauthier D.F., Hartley L.H. Impaired chronotropic response to exercise in patients with congestive heart failure. Circulation. 80:1989;314-323.
8. Nishiyana Y., Ikeda H., Haramaki N., Yoshida N., Imaizumi T. Oxidative stress is related to exercise intolerance in patients with heart failure. Am Heart J. 135:1998;115-120.
9. Persad S., Rupp H., Jindal R., Arneja J., Dhala N.S. Modification of cardiac β-adrenoceptor mechanisms by H2O2. Am J Physiol. 274:1998;H416-H423.
10. Mahler D.A., Weinberg D.H., Wells C.K., Feinstein A.R. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest. 85:1984;751-758.
11. Díaz-Araya G., Naranjo L., Godoy L., Squella J.A., Letelier M.E., Nuñez-Vergara L.J. Antioxidants effects of 1,4-dyhidropyridine and nitroso aril derivatives on brain cerebral slices. Gen Pharmacol. 31:1998;385-391.
12. McCord J, Fridovich I. Superoxide dismutase: an enzymatic function for erythrocuprein (hemocuprein). J Biol Chem 1969;22:6049-6055.
13. Misra H.P., Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem. 247:1972;3170-3175.
14. Beers R., Sizer I. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem. 195:1952;133-140.
15. Paglia D.E., Valentine W.N. Studies on quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 70:1967;158-169.
16. Khaper N., Rigatto C., Seneviratne C., Li T., Singal P.K. Chronic treatment with propranolol induces antioxidant changes and protects against ischaemia-reperfusion injury. J Mol Cell Cardiol. 29:1997;3335-3344.
17. Kukin M., Kalman J., Charney R., Levy D., Buchholz-Varley C., Ocampo O., Eng C. Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure. Circulation. 99:1999;2645-2651.
18. Chidsey C.A., Harrison D.C., Branwald E. Augmentation of the plasma norepinephrine response to exercise in patients with congestive heart failure. N Engl J Med. 276:1962;650-654.
19. Díaz-Velez C.R., Garcia-Castineiras S., Mendoza-Ramos E. Increased malondialdehyde in peripheral blood of patients with congestive heart failure. Am Heart J. 131:1996;146-152.